All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...

Healthcare & Pharmaceuticalscategory Merck to stop lung condition drug study early due to strong efficacy data 11:48 AM UTC ...